1-6 of 6
Albrecht Stenzinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAF V600E -mutated multiple myeloma

Free
Clinical Trials & Observations Brief Report
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M. Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, K. Martin Kortüm, Carsten Müller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja Weisel, Marc S. Raab
Journal: Blood
Blood (2023) 141 (14): 1685–1690.
https://doi.org/10.1182/blood.2022017789
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and Preliminary Efficacy Results from a Phase II Study Evaluating Combined BRAF and MEK Inhibition in Relapsed/Refractory Multiple Myeloma (rrMM) Patients with Activating BRAF V600E Mutations: The GMMG-Birma Trial

Free
Marc S. Raab, MD, Nicola Giesen, MD, Christof Scheid, MD, Britta Besemer, Kaya Miah, Axel Benner, Ivana Metzler, MD, Cyrus Khandanpour, PD, MD, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, MD, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Hartmut Goldschmidt, MD, Katja Weisel, MD, Manik Chatterjee
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-142600
Published: 2020
Journal Articles

Profiling of Oncogenic Signaling in Multiple Myeloma — Association with Biology, Disease Progression and Prognosis

Free
Nicola Lehners, Jing Xu, Thomas Hielscher, Leo Rasche, Elena Ellert, Albrecht Stenzinger, Peter Schirmacher, Carsten Müller-Tidow, MD, Hartmut Goldschmidt, MD, Mindaugas Andrulis, Niels Weinhold, PhD, Marc S Raab, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3206.
https://doi.org/10.1182/blood-2018-99-116214
Published: 2018
Journal Articles

Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemia

Free
Clinical Trials & Observations
Tilmann Bochtler, Martin Granzow, Friedrich Stölzel, Christina Kunz, Brigitte Mohr, Mutlu Kartal-Kaess, Katrin Hinderhofer, Christoph E. Heilig, Michael Kramer, Christian Thiede, Volker Endris, Martina Kirchner, Albrecht Stenzinger, Axel Benner, Martin Bornhäuser, Gerhard Ehninger, Anthony D. Ho, Anna Jauch, Alwin Krämer
Journal: Blood
Blood (2017) 129 (10): 1333–1342.
https://doi.org/10.1182/blood-2016-09-738161
Published: 2017
Includes: Supplemental data
Journal Articles

Absence Of BRAF and KRAS Hotspot Mutations In Primary Mediastinal and Other Diffuse Large B-Cell Lymphoma

Free
Philipp D Nagel, Fenja M Feld, Stephanie E Weissinger, Albrecht Stenzinger, MD, Peter Moeller, Jochen K Lennerz, MD PhD
Journal: Blood
Blood (2013) 122 (21): 4325.
https://doi.org/10.1182/blood.V122.21.4325.4325
Published: 2013
Journal Articles

BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Free
e-blood
Felix Sahm, David Capper, Matthias Preusser, Jochen Meyer, Albrecht Stenzinger, Felix Lasitschka, Anna-Sophie Berghoff, Antje Habel, Marion Schneider, Andreas Kulozik, Ioannis Anagnostopoulos, Leonhard Müllauer, Gunhild Mechtersheimer, Andreas von Deimling
Journal: Blood
Blood (2012) 120 (12): e28–e34.
https://doi.org/10.1182/blood-2012-06-429597
Published: 2012
Includes: Supplemental data